BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29198386)

  • 1. X-Linked Glomerulopathy Due to COL4A5 Founder Variant.
    Barua M; John R; Stella L; Li W; Roslin NM; Sharif B; Hack S; Lajoie-Starkell G; Schwaderer AL; Becknell B; Wuttke M; Köttgen A; Cattran D; Paterson AD; Pei Y
    Am J Kidney Dis; 2018 Mar; 71(3):441-445. PubMed ID: 29198386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked Alport syndrome presenting in mother and son with the same unique histopathological features.
    Bergeron NAD; Garneau AP; Rousseau-Gagnon M; Riopel J; Isenring P
    J Nephrol; 2024 Apr; 37(3):769-772. PubMed ID: 38668984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Mutations of
    Gong WY; Liu FN; Yin LH; Zhang J
    Biomed Res Int; 2021; 2021():6664973. PubMed ID: 33748275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece.
    Hadjipanagi D; Papagregoriou G; Koutsofti C; Polydorou C; Alivanis P; Andrikos A; Christodoulidou S; Dardamanis M; Diamantopoulos AA; Fountoglou A; Frangou E; Georgaki E; Giannikouris I; Gkinis V; Goudas PC; Kalaitzidis RG; Kaperonis N; Koutroumpas G; Makrydimas G; Myserlis G; Mitsioni A; Paliouras C; Papachristou F; Papadopoulou D; Papagalanis N; Papagianni A; Perysinaki G; Siomou E; Sombolos K; Tzanakis I; Vergoulas GV; Printza N; Deltas C
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife.
    Żurowska AM; Bielska O; Daca-Roszak P; Jankowski M; Szczepańska M; Roszkowska-Bjanid D; Kuźma-Mroczkowska E; Pańczyk-Tomaszewska M; Moczulska A; Drożdż D; Hadjipanagi D; Deltas C; Ostalska-Nowicka D; Rabiega A; Taraszkiewicz J; Taranta-Janusz K; Wieczorkiewicz-Plaza A; Jobs K; Mews J; Musiał K; Jakubowska A; Nosek H; Jander AE; Koutsofti C; Stanisławska-Sachadyn A; Kuleszo D; Ziętkiewicz E; Lipska-Ziętkiewicz BS
    Kidney Int; 2021 Jun; 99(6):1451-1458. PubMed ID: 33309955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
    Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R
    Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhang P; Zhuo L; Zou Y; Li G; Peng K
    Clin Nephrol; 2019 Aug; 92(2):98-102. PubMed ID: 31198170
    [No Abstract]   [Full Text] [Related]  

  • 19. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
    Savige J
    Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-collagen genes role in digenic Alport syndrome.
    Daga S; Fallerini C; Furini S; Pecoraro C; Scolari F; Ariani F; Bruttini M; Mencarelli MA; Mari F; Renieri A; Pinto AM
    BMC Nephrol; 2019 Feb; 20(1):70. PubMed ID: 30808327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.